baber/WOPTO huggingface dataset:
Patent JP-2001509283-A (JP)
Title: 音楽チップ
IPC: G10H1/16
Filed: 1997-12-15
Abstract: (57)【要約】
この発明は、滑らかなクリッピング機能（２５）を伴うデジタル処理装置およびそれを用いるデジタル音楽トーン合成装置を開示する。１つまたは複数のデジタル値がこのデジタル処理装置に入力され滑らかなクリッピングモードが活性化されると、その装置の内部の結果値が出力前にスケールダウンされるため、デジタル値の処理中におけるオーバフローが回避される。内部の結果値のスケールダウンは、オーバフローが回避されるように、内部の結果値の値の増大に依存して連続的に増大される。たとえば、このデジタル処理装置がデジタル音楽トーン形成装置において２つのデジタルオペランドの合計を実行している場合には、結果のトーン信号の傾斜の時間動作が滑らかになり、したがって、音声再生中において音声ダイナミックス改善され音声歪みが回避される。
Patent JP-2000508100-A (JP)
Title: 宛先をデジタルデータに変換した後で文書に記載されたこの宛先を自動的に評価するための方法
IPC: G06V30/262
Filed: 1997-03-18
Abstract: (57)【要約】
宛先に含まれる文字ストリングを識別及び評価しこの宛先を受取人に配布するために、各受取人に対して一義的な宛先指定を有する記憶されたパターンと宛先の文字ストリングとを比較する。この宛先の文字ストリングと最も類似したパターンが選択される。これは、宛先とパターンとの間の類似性を定義する距離尺度を形成し、次いでこの距離尺度が所定の閾値を上回るか又は下回るかを調べることによって行われる。この距離尺度がこの所定の閾値を下回る場合、このパターンに割り当てられた受取人が送出される。
Patent JP-2001512411-A (JP)
Title: セラミック繊維の圧縮物品を製造する方法及びそれにより得られる圧縮物品
IPC: C04B35/80
Filed: 1998-02-12
Abstract: (57)【要約】
模様付き表面及び集成本体を有する圧縮された耐火性繊維成形物の製造方法が開示される。積もった形態の耐火性繊維の小さなばらばらの断片がコロイド状分散液中に懸濁される。断片及び分散液は、穏やかに混合されて、繊維断片が完全には分散されずに、むしろ結果のブレンド中に繊維の小球体を形成するようにする。得られる材料は、成形され、例えば加圧下に成形され、そして普通は加圧中に乾燥される。結果の成形された物体は、模様付き表面及び集成本体に加えて、優れた断熱性、及び望ましい柔軟性ならびに引張り強度を有し得る。
Patent JP-H11504835-A (JP)
Title: 強度を増強したレーザー媒介の組織接合のための方法
IPC: A61B17/00
Filed: 1996-06-03
Abstract: (57)【要約】
増殖因子や止血剤のような生物学的に活性な因子を取り込んだ接合物(solder)を使用する組織を接合するための方法が開発された。改善された接合物組成物もまた規定され、これはタンパク質濃度の関数としてより強い破裂強度を生じ、そしてタンパク質の使用によりレーザー媒介の変性の前に折り畳みを展開し(unfolding)、そして結合する。組織の併置が不可能な場所での欠損を充填するための柱状物を形成するために、接合物濃縮物と組み合わせて発光団として水を使用する、瘻孔の修復のための方法が見出された。二極性の電気外科手術および光を含む、他の形態の指向性のエネルギーと共に使用するための方法もまた、適用された。単独、および接合指向性物の濃度の関数として、接合物内への増殖因子の取り込みにより修復強度が増加する例が実施された。トロンビン、または血管収縮薬であるエピネフリンのような、止血剤の取り込みによって出血を妨げることにより、接着の増強が得られる。
Patent JP-2001513931-A (JP)
Title: セキュリティチェックの実行
IPC: G07C9/00
Filed: 1998-03-02
Abstract: (57)【要約】
セキュリティチェックを行う方法および装置を開示する。多くの通常のセキュリティチェックは、各承認されたユーザと関係付けられたユーザデータについての組の記録または送信を要求する。ユーザデータの組が承認されていない人によって知られると、これらのシステムに関して問題が生じる。この問題を扱うために、本発明はシステムの安全でない部分の中のユーザデータの組の一部分のみを記録または送信することを提案する。例えば、共有コンピュータ(20)への承認されていない遠隔のアクセスを防ぐセキュリティチェックは、ユーザのアイリスを表すユーザデータの組を捕捉し、ユーザのパーソナルコンピュータ(10)を動作して、共有コンピュータ(20)によって要求される捕捉されたデータの組の一部のみを選択し、該部分を遠隔通信ライン(16)に沿って送信することによって行われる。共有コンピュータ(20)は、パーソナルコンピュータ(10)によって使用されるユーザデータと類似した選択を使って、記憶されたユーザデータの組から部分的なデータの組を導き出し、アクセスを認めるか否かを判断するにあたって、導き出された部分的なデータの組を、パーソナルコンピュータ(10)によって送られる部分的なデータの組とを比較する。ポイントオブセール装置および部分的なユーザデータの組のみを記録するカードも開示されている。
Patent JP-2000509211-A (JP)
Title: 半導体ウェハー表面からフォトレジストをクリーニングし、ストリッピングする方法
IPC: H01L21/3065
Filed: 1997-04-23
Abstract: (57)【要約】
特にビアホール内のレジスト層を除去する方法は、有機化合物を除去するためのプラズマを有し、脱イオン水でデバイスを洗浄し、そして有機化合物を除去するためにアルゴンスパッタリングすることを有している。洗浄とスパッタリングの順序は逆にできる。この方法は、酸及び工業用溶剤の使用を避けられる。
Patent JP-2001519076-A (JP)
Title: 金属−酸素−炭素電界エミッタ
IPC: H01J1/304
Filed: 1998-04-01
Abstract: (57)【要約】
金属−酸素−炭素電界放出電子エミッタ組成物及びそれから製造される電界放出陰極が開示される。金属−酸素−炭素ウイスカの電界エミッタの製造法、即ち金属基材（例えばタングステン線）を有機重合体でコーテイングし、不活性な雰囲気中で約１１００−約１５５０℃の温度まで約１５分−約２時間加熱する方法も開示される。この加熱温度は、触媒、例えば銅−ニッケル合金触媒の存在下に加熱を行う場合には低下させることができる。本発明のエミッタ組成物及び電界放出陰極は真空電子用途及びデバイス（例えばパネルデイスプレイ）に有用である。
Patent JP-2001519846-A (JP)
Title: 布帛柔軟用に有効な組成物及びその製造方法
IPC: D06M13/328
Filed: 1998-03-31
Abstract: (57)【要約】
加水分解安定な柔軟剤、洗剤、クリーナー又はパーソナルケアー製品における、式(I)Ｒ 1 Ｒ 2 Ｒ 3 Ｎ、式(II)Ｒ 1 Ｒ 2 Ｒ 3 Ｎ（ＨＡ） y もしくは式(III)Ｒ 1 Ｒ 2 Ｒ 3 Ｎ（ＱＡ） y の１つで表される化合物、又はこれらの化合物の２種以上の混合物の使用。上式中、Ｒ 1 は独立に式Ｒ 6 -(ＯＣＨＲ 5 -ＣＨ 2 ) a ‐ＯＣＨＲ 4 -ＣＨ 2 -又はＣ n Ｈ (2n+1-x) (ＯＲ 8 ) x を有する基であり、Ｒ 2 及びＲ 3 は各々独立に、Ｃ 1 −Ｃ 4 アルキル基、式Ｒ 6 -(ＯＣＨＲ 5 -ＣＨ 2 ) a ‐ＯＣＨＲ 4 -ＣＨ 2 -又はＣ n Ｈ (2n+1-x) (ＯＲ 8 ) x を有する基であり、Ｒ 4 はＨ又はＣ 1 -Ｃ 4 アルキル基であり、Ｒ 5 は独立に、Ｈ又はＣ 1 -Ｃ 4 アルキル基であり、好ましくはＲ 5 の少なくとも１個はＣ 1 -Ｃ 4 アルキル基であり、Ｒ 6 はＨ又はＲ 7 -ＣＯ−であり、Ｒ 7 はＣ 5 -Ｃ 35 、好ましくはＣ 8 -Ｃ 23 の直鎖もしくは分枝鎖飽和もしくは不飽和アルキルであり、Ｒ 8 は独立に、Ｈ又はＲ 7 −ＣＯ−、又はＲ 6 -(ＯＣＨＲ 5 -ＣＨ 2 ) a であり、ａは独立に、０〜30、好ましくは０〜６の数であり、ｎ及びｘは独立に２〜６の数であり、Ａは無機もしくは有機酸アニオンであり、ＱはＣ 1 -Ｃ 5 アルキル、所望によりアルキルで置換したＣ 6 -Ｃ 12 アリール、又はＨＯ−ＣＨＲ 9 -ＣＨ 2 -基（式中、Ｒ 9 はＨ又はＣ 1 -Ｃ 4 アルキルである）であり、各々独立に、０＜ｙ≦１であり、但しＲ 7 -ＣＯ−基の少なくとも１つがこの化合物中に存在し、Ｒ 6 -(ＯＣＨＲ 5 -ＣＨ 2 ) a 基の少なくとも１つはこの化合物中に存在し、ａの少なくとも１つは０ではない。
Patent JP-2000511425-A (JP)
IPC: A61K47/48
Filed: 1997-05-30
Abstract: A monoclonal antibody, or fragments thereof, having binding specificity for both endoglin expressed on human vascular endothelial cells and on murine endothelial cells. Antiangiogenic therapy in mammals can be effected by administering to the mammalian host a therapeutically effective amount of an anti-endoglin monoclonal antibody, or fragment thereof, which is conjugated to at least one angiogenesis inhibitor or antitumor agent. The composition is useful for treating tumor and angiogenesis-associated diseases.
Patent JP-2001517956-A (JP)
Title: 組織特異的プロモーター
IPC: C12N15/09
Filed: 1998-03-24
Abstract: (57)【要約】
本発明は、組織特異的および細胞型特異的なプロモーター活性を有するヒト・インボルクリン(hINV)配列を提供する。本発明により提供される配列は層形成上皮の基底上細胞(suprabasal cell)への発現を指令する。本発明はさらに、ヒト・パピローマウイルス16癌遺伝子の発現を指令するhINVプロモーター配列を含むトランスジェニック動物を提供する。これらの動物は頸部および表皮の過形成ならびに気管、食道、結腸、表皮、肛門／直腸、リンパ節、脾臓および肺の癌を示す。本発明の動物は潜在的な抗腫瘍性化合物、発癌物質、およびいくつかの癌の発癌補助物質をスクリーニングするための有用なモデルを提供する。
Patent JP-2001520676-A (JP)
Title: ホルミルホスホン酸の製造方法
IPC: C07B/
Filed: 1998-05-04
Abstract: (57)【要約】
ホルミルホスホン酸誘導体を製造するための改良法が開示されている。アミノメチルホスホン酸基質を、水、アルコール、フェノール化合物およびこれらの混合物からなる群から選択される試薬ならびに酸化性ガスと、触媒の存在下に接触させて、ホルミルホスホン酸誘導体を含有する反応生成物混合物を生成させ、そして、該接触を行う条件を、反応生成物混合物中に生成するホルミルホスホン酸誘導体の５０％以下が試薬との反応によって消費されるように制御する。
Patent JP-H06280042-A (JP)
Title: Coated metal article
Inventor: RONARUDO ERU ANDORASU
IPC: C23C26/00
Filed: 1989-08-02
Abstract: PURPOSE: To provide an oxygen barrier coating increased in reliability to superalloy and having reproducibility by regulating the total amount of additives in the case of barium silicate series and that in the case of strontium silicate series to specific percentages, respectively.  
     CONSTITUTION: The metal alloy bas is material of an article to be coated is selected from nickel-base alloy, chromium-base alloy, etc. Then, coating is applied to its metal surface. The coating is constituted of glass-ceramics which has a composition capable of forming an oxide barrier on the metal surface and selected from barium silicate, etc. The composition contains, by weight percentage on an oxide basis, 20-65% BaO and 25-65% SiO 2 , in the case of barium silicate series. The series contains ≤15% Al 2 O 3 , etc., and ≤25% ZrO 2 , etc. Further, B 2 O 3 +R 2 O in an amount not exceeding 5% is incorporated. The total amount of the additives is regulated so that it does not exceed 50% in the case of barium silicate series and 40% in the case of strontium silicate, respectively. By this method, the coating, more effective than the conventional coating and easy of application, can be provided. 
     COPYRIGHT: (C)1994,JPO
Patent MD-20060201-A (MD)
Inventor: SAROV VALERII
IPC: G10C3/00
Filed: 2006-08-03
Abstract: Inventia se refera la instrumente muzicale, si anume la instrumentele muzicale cu clape-strune de tip pian si la instrumentele muzicale cu ancie de tip acordeon. Instrumentul muzical contine corp, placa de rezonanta, surse de sunet, elemente mobile de dirijare, traductoare de deplasare a elementelor mobile de dirijare, elemente mobile dirijate de activare a sunetului, de exemplu, ciocane de percutie, surdine, clapete, fixate fiecare pe levierul sau. Esenta instrumentului muzical consta in aceeaca levierele  mobile ale elementelor de activare a sunetului sunt executate din material lamelar piezoceramic de tip incovoietor, si anume piezobimorf. Dirijarea tuturor proceselor de functionare a instrumentului muzical se realizeaza prin intermediul unui bloc microprocesor inclus care, impreuna cu utilizarea materialului piezobimorf, extinde substantial posibilitatile interpretative ale instrumentelor muzicale si sporesc siguranta lor.
Patent MX-157693-A (MX)
Inventor: MAUL PETER L
IPC: C04B14/08
Filed: 1982-11-22
Abstract: A masonry cement is prepared by dry mixing portland cement, diatomaceous earth and a water-swellable colloidal clay, such as bentonite. Accordingly, the crushed limestone and other ingredients previously included in masonry cements for admixture with portland cement can be completely eliminated and substituted by diatomacious earth and water-swellable colloidal clay. In this manner, a combination of less than about 10% by weight of a combination of diatomaceous earth and colloidal clay replaces approximately 50% by weight crushed limestone and other ingredients from prior art masonry cement compositions while providing a masonry cement which meets ASTM specifications, particularly for air entrainment, water retention and compressive strength.
Patent NZ-206177-A (NZ)
Title: Piperidinedione derivatives and pharmaceutical compositions
Inventor: BERNHART C
IPC: C07D401/04
Filed: 1983-11-07
Abstract: The present invention relates to derivatives of piperidinedione of formula:    <IMAGE>  (I)  in which R is alkyl or forms with N a possibly substituted morpholino or piperidino group, n=2 or 3, R1, R2, R3 and R4 represent H or lower alkyl; R3 and R4 taken together may represent (CH2)m where m=4 or 5 and R2 and R3 taken together may represent (CH2)p where p=3 or 4 and in this case R1 and R4=H, R5 is H or alkyl. It also relates to a process for manufacturing the product of formula (I) and to the drugs containing a product of formula (I).
Patent NZ-212841-A (NZ)
Title: Fractionating high yield pulp into long-fibre and fine-fibre fractions
Inventor: LINDAHL J A I
IPC: D21B1/14
Filed: 1985-07-23
Abstract: An improved high yield pulp, such as groundwood pulp, thermomechanical pulp, chemimechanical pulp and waste paper pulp having a widened field of use is produced by treating the raw material in a known manner, screening, thickening and bleaching, the pulp subsequent to being bleached at a low pulp consistency being mechanically worked and divided in a fractionating apparatus into a long-fibre fraction and a fine-fibre fraction. The freeness of the long-fibre fraction exceeds and freeness of the fine-fibre fraction by 150-600 ml C.S.F. and the fine-fibre fraction constituents 35-70 % by weight of the pulp quantity obtained after the bleaching stage.
Patent NZ-222741-A (NZ)
Title: Pharmaceutical compositions containing an interferon and a purine derivative
Inventor: COLE MARTIN
IPC: A61K31/52
Filed: 1987-11-30
Abstract: Pharmaceutical product comprising an interferon and a compound of formula (A) <CHEM> or a pro-drug, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing as a combined preparation for simultaneous, separate or sequential use in antiviral therapy.
Patent NZ-224331-A (NZ)
Title: Ceramic articles with small flaws
Inventor: ALFORD NEIL MCNEIL
IPC: C04B35/58
Filed: 1988-04-21
Abstract: A process for the production of a shaped article of a ceramic material in which a composition comprising particulate ceramic material and a liquid medium is shaped, the liquid medium is removed from the shaped composition, and the composition is heated to sinter the particles of ceramic material in which the composition is subjected to high shear mixing such that in the shaped article which is produced the mean maximum size of flaw is less than 25 microns. Also, a shaped article of sintered particulate ceramic material in which the mean maximum size of flaw is less than 25 microns and in which the minimum dimension of the shaped article is in excess of 0.1 mm.
Patent NZ-224520-A (NZ)
Title: Delivery systems for the controlled administration of lhrh analogs
Inventor: SANDERS LYNDA MARY
IPC: A61K9/22
Filed: 1988-05-06
Abstract: An implantable polymeric delivery system for the controlled and continuous administration of an LHRH analog which comprises a silicone elastomer matrix in which is dispersed about 30 to about 42 weight percent of water-soluble particulate phase containing an LHRH analog or a pharmaceutically acceptable salt thereof.
Patent NZ-232539-A (NZ)
Title: Snap-fitting bayonet type tube coupling
Inventor: ROMAN GIANFRANCO
IPC: F16L37/24
Filed: 1990-02-14
Abstract: The fitting element is constituted by a male element (1), with a hollow cylindrical tang (4) having a plurality of ribs (5), arranged axially and protruding in a radial direction, and by a female element (2), essentially constituted by a hollow cylindrical casing (7) suitable for receiving tang (4) of male element (1). On the inside wall (21) of female element (2) there is obtained a plurality of grooves (10) suitable for receving by axial sliding the corresponding ribs (5); each of said grooves (10) is flanked by a lateral seat (13), which receives one of said ribs (5) following the rotation, subsequent to the axial sliding, of male element (1).
Patent NZ-233382-A (NZ)
Title: Shaped catalytic particles comprising a calcium aluminate cement and nickel oxide and/or cobalt oxide
Inventor: KING FRANK
IPC: C02F1/58
Filed: 1990-04-19
Abstract: Shaped particles suitable for use as a catalyst, or precursor thereto, particularly for the decomposition of hypohalite ions in aqueous solution, comprising a calcium aluminate cement and at least one oxide of a Group VIII metal M selected from nickel and cobalt, said particles containing 10 to 70% by weight of said Group VIII metal oxide (expressed as the divalent oxide, MO) and having a porosity in the range 25 to 50%, in which at least 30% of the pore volume is in the form of pores of size in the range 15 to 35 nm and less than 40% of the pore volume is in the form of pores of diameter greater than 35 nm.
Patent NZ-237303-A (NZ)
Title: Dibenzylidene xylonic acid derivatives suitable as clarifying additives for polyolefins; polyolefin compositions comprising such additives
Inventor: MILLNER O ELMO
IPC: C08L67/00
Filed: 1991-03-04
Abstract: Dibenzylidene xylonates are a new class of clarifiers for polyolefins. The invention includes polyolefin compositions having the new clarifiers therein.
Patent NZ-242939-A (NZ)
Title: Composition for use as a scale deposit control agent comprising a polyether polyamino methylene phosphonate derivative
Inventor: SHIH-RUEY THOMAS CHEN
IPC: C08L71/02
Filed: 1992-05-28
Abstract: Polyether polyamino methylene phosphonates possess high calcium tolerance and have been found to give excellent inhibition of the formation, deposition and adherence of scale-forming salts, especially calcium carbonate, under severe conditions which include elevated pH, high dissolved solids content, and high saturation levels of calcium carbonate.
Patent NZ-250634-A (NZ)
Title: Security document with cancellation term visible on a colour copy of the document
Inventor: MOWRY WILLIAM H
IPC: G03C5/08
Filed: 1994-01-06
Abstract: An improved security document according to the present invention includes a substrate having a surface for carrying indicia. The document has background printed matter, consisting of a pattern of elements of a first size and frequency, printed at a first density on the surface. The document further has a cancellation term, consisting of a pattern of elements of a second size and frequency, printed at a second density on the surface. Elements of one of the first size or the second size are sufficiently small such that they are not reproduced by a color copier at a particular copier setting, and elements of the other of the first size or the second size are sufficiently large such that they are reproduced by the color copier at the particular copier setting. As a result, a copy of the security document made on a color copier displays the cancellation term. At least a portion of the security document surface is divisible into a plurality of bands extending across the surface. The sizes of the elements and the density of the background printed matter and the cancellation term vary together across the bands in a direction generally normal to the bands. As an alternative, the frequencies of the elements may vary across the bands such that the density of the background printed matter and the density of the cancellation term are changed. Such a document may be printed with different colors of ink on different portions of the document, and with the bands in which a color transition occurs being printed with two colors of ink at differing screen angles. <IMAGE>
Patent NZ-253405-A (NZ)
Title: Minimising progestin-associated breakthrough bleeding; contraceptive comprising progestin and antiprogestin
Inventor: HODGEN GARY D
IPC: A61P43/00
Filed: 1993-05-03
Abstract: A method for minimizing menstrual bleeding irregularities in individuals using progesting-only pharmaceutical preparations, such as contraceptives, is disclosed.
Patent NZ-260378-A (NZ)
Title: Multifocal opthalmic lens with surface spiral pattern providing different dioptric powers
Inventor: XIAOXIAO ZHANG
IPC: G02C7/04
Filed: 1994-04-22
Abstract: A multifocal ophthalmic lens has a spiral-like pattern on its surface in an area overlying the cornea of a wearer of the lens. The spiral-like pattern is capable of providing a plurality of different dioptric powers. <IMAGE>
Patent NZ-272528-A (NZ)
Title: Abdominal exerciser: upper body positioned between a rockable frame
Inventor: BROWN DONALD
IPC: A63B23/02
Filed: 1995-07-07
Abstract: The abdominal exerciser device is made of a one piece skeletal frame. The frame defines a pair of support rails, a pair of arcuate rocker portions, a pair of arm rest portions and an arch-shaped portion connecting the support rails together. Removable cushions are disposed on the arm rest portions to receive the elbows of the user when in a supine position. The head and neck of a user are supported on a head rest which is secured to the arch-shaped portion. The rocker portions are curved on a circular arc to mimic the curvature of the spine of the user.
Patent NZ-274164-A (NZ)
Title: Preparation of anti-fungal compositions of polyene type compounds (such as natamycin) which are incorporated into the compositions in a modified form; use in or on foodstuffs and anti-fungal activity assay
Inventor: VAN RIJN FERDINAND THEODORUS J
IPC: A01N63/02
Filed: 1994-09-28
Abstract: The present invention provides a method of preparing an improved antifungal composition containing an antifungal compound of the polyene type such as natamycin wherein the antifungal compound is incorporated into the composition in a form which shows an enhanced activity, e.g. in the form of a solution and/or being in a modified polymorphic form.
Patent NZ-309624-A (NZ)
Title: Non-irritating, non-sensitizing, non-ototoxic (harmful to the ears) antibacterial compositions
Inventor: PURWAR SHIVAJI
IPC: A61K9/10
Filed: 1996-06-05
Abstract: The invention is directed to an aqueous non-ototoxic, topical, otic pharmaceutical composition of matter for treating a mammal consisting essentially of: ciprofloxacin or a pharmaceutically acceptable salt thereof in aqueous solution in an amount effective for antibacterial action; hydrocortisone or a pharmaceutically acceptable salt thereof in an amount effective as an anti-inflammatory agent; polyvinyl alcohol at least about 85% hydrolyzed in an amount effective to suspend the hydrocortisone in solution; water sufficient to produce an aqueous composition; benzyl alcohol in an amount effective for antibacterial action; lecithin in an amount effective for enhancing suspension of other constituents in the composition; and polysorbate ranging from polysorbate 20 to 80 in an amount effective for spreading the preparation on a hydrophobic skin surface to the site of infection or inflammation.
Patent NZ-332004-A (NZ)
Title: The use of inhibitors of the Na+/H+ exchanger for the treatment or prophylaxis of disorders of the CNS (Central Nervous System)
Inventor: BINGMANN DIETER
IPC: A61K31/425
Filed: 1998-09-22
Abstract: Provided is the treatment of disturbances of the central nervous system, such as hyperexcitability of neurons, epilepsies and affective psychoses and anxiety disorders occurring under nonischemic conditions, using an inhibitor of the Na+/H+ exchanger.  Preferably these inhibitors are guanidine derivatives, more preferably benzoylguanidine derivatives, especially cariporide.
Patent NZ-338004-A (NZ)
Title: Process for producing peptide with glucagon like peptide-1 (GLP-1) activity by incorporating a protective and helper component to facilitate purification
Inventor: OHSUYE KAZUHIRO
IPC: C12N15/62
Filed: 1999-01-29
Abstract: The production of peptides having a desired biological activity using genetic engineering technology characterised in that the peptide of interest is expressed with addition of a helper peptide. This results in a higher purification efficiency and yield of the peptide of interest. The recovery of the peptide of interest is further enhanced through the prevention of aggregation during the recovery and/or purification by adjusting the isoelectric points during ion exchange chromatography. The process is further characterised by cleaving the fusion protein enzymatically for release of the peptide of interest. The purification of glucagons-like peptide-1 (GLP-1) and derivatives are described.
Patent NZ-500784-A (NZ)
Title: Portable and lockable enclosure with visual, audible and electromagnetic warning means and time delay means
Inventor: CURTIS ANDREW DAVID RANGI
IPC: A45C1/12
Filed: 1999-11-03
Abstract: A portable and lockable enclosure 25 comprises a lid 27 or drawer, a storage battery, audible warning means 23, visual warning means 24, electromagnetic warning means (e.g. a radio transmitter), time delay means, on/off switching means 1, 16, locking means 28 to secure the lid or drawer to the main body of the enclosure and actuating means 3.  The warning means, when actuated, continues to function unless interrupted by the on/off switching means.  When an actuating switch means 3 is closed then latching relay 4 and electric motor 9 are energized by a storage battery 2 and when motor 9 is energized, shaft 10 and small cog 11 revolve.  Since cog 11 is closely associated with a large cog 12, then cog 12 with fixed peg 14 revolves around axis 13.  As peg 14 revolves around axis 13 it comes into contact with and closes an actuation switching means 15.  If on/off switching means 16 is closed then relay 18, audible warning means 23 and visual warning means 24 are all energized by a storage battery 17.
Patent NZ-505991-A (NZ)
Title: Interseparation of iridium from other platinum group metals
Inventor: SMITH CHRISTOPHER STANLEY
IPC: B01D15/08
Filed: 2000-07-26
Abstract: A method for the interseparation of iridium in admixture with one or more other platinum group metals (PGM) from an acidic solution containing chlorocomplexes of these metals is described. Initially the solution is passed through at least one chromatography column containing a solid absorbant and eluting one or more fractions containing one or more PGM's, which comprises the steps of: (a) ensuring that iridium is present on the column in a tetravalent oxidation state, and (b) reducing the iridium from a tetravalent oxidation state to a trivalent oxidation state on the column, and effecting the elution of iridium (III) cholocomplex separately from cholocomplexes of other PGMs.
Patent NZ-506014-A (NZ)
Title: Use of estrogen agonists (lasofoxifene) for treating osteoporosis, cardiovascular disease and cancer without interfering with warfarin or proranolol
Inventor: YU LI JULIA
IPC: A61P35/00
Filed: 2000-07-27
Abstract: A method of treating or preventing osteoporosis, cardiovascular disease and breast cancer using an effective amount of an estrogen agonist and warfarin or propranolol.
Patent NZ-508330-A (NZ)
Title: Robotic ship fairing and painting
Inventor: MORTON JOHN STEPHEN
IPC: B05B12/00
Filed: 2000-11-22
Abstract: Ship hull 18 fairing and painting is performed by a plurality of computer 12 controlled robots 30 moveable on gantries 16, 20 and with tools 38 for hull shape determination, fairing compound spraying, fairing compound dressing, and painting.